LPAR1 and neuroblastoma: As shown in Figure 3A–D, survival analysis revealed that a poor prognosis was significantly associated with low LPAR1 mRNA levels in NB patients (bonf p <0.05), which was the same for FN1, PIK3R5 and LPAR6.